← Leaderboards
Timothy P Coleman
Nemucore Medical Innovations, Inc.
$1,558,935
Attributed
$3,632,824
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $890.5K · FY2011–15$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$3,632,824 · 4
By mechanism
R01$2,894,607 · 1
R43$449,915 · 2
U43$288,302 · 1
Top collaborators
- Mansoor M. Amiji5 shared
- Denise C Connolly5 shared
- Srinivas Ganta1 shared
Others in their field
Top investigators on “Solutions”
- Gary Craft · Ch2m Hill Constructors, Inc$155,196,016
- David Heimbrook · Leidos Biomedical Research, Inc.$144,050,416
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$87,858,851
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$72,775,159
- Joseph B Martin · Harvard University (Medical School)$72,035,324
Research focus
SolutionsInvestigationTissuesTumorClinical TrialsLaboratoriesMulti-Drug ResistanceTherapeutic AgentsToxic EffectMalignant NeoplasmsMalignant Neoplasm Of OvaryLinkRecurrenceCancer PatientIn VivoChemotherapeutic AgentInnovationRattusPhenotypeNanotechnologyNewly DiagnosedPreclinical StudyDesignMedicine
Grant awards (8)
Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer$523,530
R01 · FY2015 · CA · contact PI
Modified MIS Production & Process Development for Preclinical & Clinical Studies$225,000
R43 · FY2015 · CA · contact PI
Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer$665,610
R01 · FY2014 · CA · contact PI
Expression System and Process Development for MIS Scale Up$224,915
R43 · FY2014 · CA · contact PI
Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer$596,489
R01 · FY2013 · CA · contact PI
Targeted Docetaxel-Nanocolloid for the Treatment of Ovarian Cancer$288,302
U43 · FY2013 · CA · contact PI
Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer$540,181
R01 · FY2012 · CA · contact PI
Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer$568,797
R01 · FY2011 · CA · contact PI